echa6

GSK572A 是一种新型且强效的EchA6强效抑制剂，可用来治疗肺结核。

GSK366A is an anti-TB agent against Mycobacterium bovis BCG and Mycobacterium tuberculosis, targeting MmpL3 and inhibiting EchA6.

GSK729 is a novel potent EchA6 inhibitor.

GSK951A is an inhibitor of EchA6. GSK951A interacts with fatty acid synthase II (FAS-II), inhibits mycolic acid biosynthesis and suppresses the synthesis of all classes of MAMES in M. bovis BCG, whilst the FAMEs remain largely unaffected.